ArticleBMC microbiology2026
Effects of dietary supplementation with Enterococcus faecalis JM263 on growth performance, antioxidant status, rumen microbiota and metabolism in yaks.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundYaks are vital to the ecology and economy of the Qinghai-Xizang Plateau. The unique environmental conditions of this high-altitude region have shaped yaks, leading to significant differences in their evolution from other cattle species. From yak gut contents, we isolated Enterococcus faecalis JM263, a novel probiotic with strong fiber-degrading ability. To investigate the effects of E. faecalis JM263 on the growth performance, antioxidant capacity, rumen microbiome, and metabolites of captive yaks, we randomly allocated 32-day-old yak calves weighing 84.5 ± 3.1 kg into three distinct groups: the control group (CK) fed a basal diet, Experimental Group 1 (CYL) received a test diet supplemented with 1 mL of E. faecalis JM263 (7.0 × 10⁸ CFU/mL) in the basal diet, and Experimental Group 2 (CYH) received a test diet supplemented with 1 mL of E. faecalis JM263 (14.0 × 10⁸ CFU/mL) in the basal diet. The experimental period lasted 60 days.
resultsCompared with the CK group, the CYL group showed significantly higher final weight and average daily gain (ADG) (P < 0.05), while the CYH group exhibited no significant changes (P > 0.05). Total Antioxidant Capacity (T-AOC) in both CYL and CYH groups was significantly higher than that in the CK group (P < 0.05). while GSH-Px levels in the CYL group were significantly higher than both CK and CYH groups (P < 0.05). 16 S rRNA sequencing analysis revealed that supplementation with E. faecalis JM263 significantly altered rumen microbial communities in yaks. 16 S rRNA results indicated significantly increased relative abundances of Saccharofermentans, Succiniclasticum, Methanobrevibacter, NK4A214_group, and Christensenellaceae_R-7_group (P < 0.05), while relative abundances of Butyrivibrio and F082 significantly decreased (P < 0.05). Metabolomics analysis revealed significant upregulation (P < 0.05) of metabolites including, S(-)-Cathinone, Anisomycin, (+)-Muscarine cation, and Deoxyadenosine, in both CYL and CYH groups compared to the CK group, indicating enhanced microbial activity. The CYH group also exhibited significant upregulation of S(-)-Cathinone and (-)-Epinephrine (P < 0.05). Correlation analysis between rumen microorganisms and metabolites revealed that 2'-deoxyadenosine, phosphorylcholine, and choline cation were significantly positively correlated with bacterial taxa such as Saccharofermentans. In contrast, hypoxanthine was significantly negatively correlated with Succiniclasticum, Methanobrevibacter, Christensenellaceae_R-7_group, NK4A214_group, and Saccharofermentans.
conclusionSupplementation with E. faecalis JM263 not only improved the growth performance and antioxidant capacity of yaks, but also reshaped the rumen metabolic profile while maintaining microbial community stability, and promoted microbe-metabolite interactions, thereby jointly contributing to the regulation of rumen homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.